Change over period: —
NSE · SYMBIOTEC
SYMBIOTEC
-1.3% from the 52-week high · +61.6% above the low
1 · The price
How has the stock traded?
SYMBIOTEC trades 1.3% below its 52-week high and 61.6% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | |
|---|---|---|
| Revenue | 280 | 218 |
| Net profit | 52 | 14 |
| Net margin % | 18.5 | 6.4 |
| EPS (₹) | 8.05 | 2.2405355861959033 |
4 · The owners
Who holds it, and are they adding?
+3 versus the previous month.
Mutual fund holdings · Oct 2026
31 schemes hold this stock
28 the month before.
- Baroda BNP Paribas Focused Fund2.46% of NAV
- Mirae Asset Healthcare Fund1.66% of NAV
- Baroda BNP Paribas Health and Wellness Fund1.59% of NAV
- MOTILAL OSWAL SMALL CAP FUND1.43% of NAV
- HDFC Pharma and Healthcare Fund1.38% of NAV
- Mirae Asset Small Cap Fund1.22% of NAV
- HDFC MNC Fund1.11% of NAV
- ICICI Prudential Small Cap Fund1.1% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SYMBIOTEC are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Quick answers
Common questions about SYMBIOTEC
What is the SYMBIOTEC share price?
SYMBIOTEC (SYMBIOTEC) last closed at ₹1,602.00, down 1.19% on the day. Its 52-week range is ₹1,003.35 to ₹1,642.40.
What is the market cap of SYMBIOTEC?
SYMBIOTEC has a market capitalisation of about ₹10,419 crore. Its price-to-earnings ratio is 95.4.
How many mutual funds hold SYMBIOTEC?
31 mutual fund schemes held SYMBIOTEC in October 2026. That compares with 28 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.